Guido A Davidzon, MD
Nuclear Medicine · Emeryville
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 1
- 1 carrier
- Offices
- 6
Offices
6 locations · Stanford Health Care · 3,152 clinicians in this group
Hospitals listed: Stanford Health Care · Stanford Health Care Tri-Valley. That is not proof they admit you there this week.
Plans that list them
1 plan · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Davidzon’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A117782 · Current
Licensed to practise in California · since 2011 · expires 2027-08-31 · Maimonides University Faculty of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
State licence records
1 licence
- Illinois 036133414Licensed Physician And Surgeon · since 2013 · expires 2014-07-31Not RenewedNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
- Stanford Health Care Tri-ValleyPleasanton, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Stanford Health Care, which runs 3 hospitalsPatients rate it 3 of 5 · 74% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.178, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.237, Oct 2024 – Sep 2025
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Stanford Health Care Tri-Valley
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 7 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.178 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.237 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.79 (0 to 1.73) · 1,041 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.79 (0.5 to 1.08) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 145.81 (96.5 to 195.12) · 72 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.9 · 55 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.6 · 92 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.5 · 96 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.5 · 395 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 391 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 162 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 1,736 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.37) · 4,425 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.22 (0.02 to 0.41) · 4,771 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.45 (1.46 to 5.44) · 1,403 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.5 (0.05 to 2.94) · 645 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.81 (0.38 to 3.24) · 1,279 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.53 (3.2 to 13.85) · 639 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.15 (1.89 to 8.41) · 648 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.14 to 3.07) · 370 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.16 (0 to 0.83) · 4,160 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 74 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.369 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.112 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.1 · 110 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.1 · 437 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -5.8 · 94 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -19.3 · 456 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -0.3 · 402 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15.8 · 358 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.8 (4.7 to 9.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.1 (7.5 to 13.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.9 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 92 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.4 (9.6 to 16.2) · 1,532 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.2) · 929 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,268 patients answered, 26% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 65% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 42% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
$76,597
Medicare paid this office $76,597 for 1,296 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Nuclear medicine study from skull base to mid-thigh with ct scan | 196 | $19,608 | $99 |
| Nuclear medicine study whole body with ct scan | 66 | $6,488 | $97 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 20 | $5,743 | $273 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 86 | $5,666 | $66 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 54 | $5,536 | $101 |
See all 21 services
| Nuclear medicine study from skull base to mid-thigh with ct scan | 196 | $19,608 | $99 |
| Nuclear medicine study whole body with ct scan | 66 | $6,488 | $97 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 20 | $5,743 | $273 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 86 | $5,666 | $66 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 54 | $5,536 | $101 |
| Nuclear medicine study whole body with ct scan | 38 | $4,057 | $101 |
| Dxa bone density measurement of hip, pelvis, spine | 368 | $3,876 | $11 |
| Nuclear medicine study, spect imaging with concurrent ct scan, 1 area or single acquisition, single day imaging | 61 | $3,757 | $57 |
| Radioactive drug therapy through a vein | 31 | $3,264 | $82 |
| Nuclear medicine study limited area with ct scan | 30 | $2,619 | $87 |
| New patient visit (60+ min) | 12 | $2,341 | $195 |
| Dxa bone density measurement of hip, pelvis, spine | 203 | $2,135 | $11 |
| Nuclear medicine study, spect imaging with concurrent ct scan, at least 2 areas or separate acquisitions, single day imaging, or single area or acquisition over multiple days | 15 | $1,283 | $86 |
| Nuclear medicine study limited area | 15 | $948 | $63 |
| Nuclear medicine study, spect imaging, 1 area or single acquisition, single day imaging | 18 | $801 | $45 |
| Nuclear medicine study of stomach to assess emptying | 25 | $789 | $32 |
| Nuclear medicine study of bone and/or joint whole body | 20 | $768 | $35 |
| Nuclear medicine study of lymphatic system | 15 | $691 | $46 |
| Nuclear medicine study of lung ventilation and circulation | 11 | $489 | $44 |
| Nuclear medicine study of stomach to assess emptying | 11 | $358 | $33 |
| Piflufolastat f-18, diagnostic, 1 millicurie | 51 | $1 | $0 |
Who their Medicare patients are
1,296 Original Medicare patients in 2024. Average age 75 · Under 65 6% · 85 and older 12% · Women 64% · Also on Medicaid 21% · Health risk score 1.66. At or below the middle of the specialty; the typical nuclear medicine clinician is at 1.94.
Conditions among them: High blood pressure 66% · Cancer 34% · Diabetes 28% · Coronary heart disease 25% · Chronic kidney disease 24% · Atrial fibrillation 20% · Depression 18% · Heart failure 17% · COPD 12% · Dementia 9% · Stroke 8%.
The office billed $2,379,420, Medicare allowed $96,617 and paid $76,597; for 1,477 services of 41 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 1,296 | 1,477 | 75 | 1.66 | $2,379,420 | $76,597 |
| 2023 | 1,452 | 1,654 | 75 | 1.60 | $1,939,716 | $80,233 |
| 2022 | 1,123 | 1,257 | 74 | 1.74 | $962,817 | $71,666 |
| 2021 | 1,306 | 1,451 | 75 | 1.76 | $938,504 | $88,571 |
| 2020 | 1,135 | 1,233 | 73 | 1.89 | $773,283 | $77,175 |
| 2019 | 1,585 | 1,710 | 73 | 1.84 | $648,070 | $89,638 |
| 2018 | 1,998 | 2,199 | 73 | 1.79 | $660,026 | $106,842 |
| 2017 | 1,092 | 1,312 | 72 | 2.09 | $616,167 | $104,365 |
| 2016 | 416 | 461 | 72 | 1.99 | $209,773 | $36,387 |
| 2014 | 529 | 567 | 72 | 1.89 | $119,756 | $21,066 |
| 2013 | 531 | 562 | 70 | 1.53 | $116,899 | $19,525 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 22 services
| Nuclear medicine study from skull base to mid-thigh with ct scan | 212 | $22,810 | $103 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 72 | $7,828 | $104 |
| Nuclear medicine study whole body with ct scan | 60 | $6,689 | $105 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 95 | $6,541 | $69 |
| Dxa bone density measurement of hip, pelvis, spine | 561 | $6,132 | $11 |
| Nuclear medicine study, spect imaging with concurrent ct scan, 1 area or single acquisition, single day imaging | 69 | $4,489 | $62 |
| Radioactive drug therapy through a vein | 34 | $3,345 | $84 |
| Nuclear medicine study whole body with ct scan | 26 | $2,852 | $102 |
| New patient visit (60+ min) | 13 | $2,171 | $167 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan | 20 | $1,631 | $82 |
| Dxa bone density measurement of hip, pelvis, spine | 142 | $1,531 | $11 |
| Calculation of radiation therapy dose | 34 | $1,212 | $31 |
| Nuclear medicine study of lymphatic system | 20 | $1,028 | $51 |
| Nuclear medicine study of heart muscle with metabolic evaluation and concurrent ct scan | 14 | $1,024 | $73 |
| Nuclear medicine study, spect imaging, 1 area or single acquisition, single day imaging | 20 | $928 | $46 |
| Nuclear medicine study of bone and/or joint whole body | 23 | $837 | $36 |
| Nuclear medicine study of stomach to assess emptying | 24 | $823 | $34 |
| Nuclear medicine study of heart muscle at rest and with stress and spect | 12 | $716 | $60 |
| Nuclear medicine study of lung ventilation and circulation | 15 | $692 | $46 |
| Nuclear medicine study, whole body | 15 | $513 | $34 |
| Nuclear medicine study, 1 area | 14 | $392 | $28 |
| Piflufolastat f-18, diagnostic, 1 millicurie | 16 | $0 | $0 |
2022: 17 services
| Nuclear medicine study from skull base to mid-thigh with ct scan | 237 | $24,960 | $100 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 77 | $8,016 | $98 |
| Nuclear medicine study whole body with ct scan | 63 | $6,428 | $100 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 86 | $5,615 | $65 |
| Dxa bone density measurement of hip, pelvis, spine | 328 | $3,613 | $11 |
| Nuclear medicine study, spect imaging with concurrent ct scan, 1 area or single acquisition, single day imaging | 58 | $3,604 | $61 |
| Nuclear medicine study whole body with ct scan | 36 | $3,569 | $96 |
| Radioactive drug therapy through a vein | 21 | $2,280 | $84 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan | 16 | $1,274 | $80 |
| Nuclear medicine study of bone and/or joint whole body | 31 | $1,075 | $35 |
| Nuclear medicine study of lymphatic system | 20 | $981 | $49 |
| Dxa bone density measurement of hip, pelvis, spine | 73 | $789 | $11 |
| Calculation of radiation therapy dose | 21 | $739 | $31 |
| Nuclear medicine study of stomach to assess emptying | 18 | $594 | $31 |
| Nuclear medicine study of lymphatic system | 11 | $571 | $52 |
| Nuclear medicine study of lung ventilation and circulation | 11 | $510 | $46 |
| Nuclear medicine study, whole body | 12 | $414 | $35 |
2021: 14 services
| Nuclear medicine study from skull base to mid-thigh with ct scan | 322 | $35,097 | $103 |
| Nuclear medicine study whole body with ct scan | 108 | $12,046 | $105 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 113 | $7,724 | $68 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 59 | $6,673 | $108 |
| Dxa bone density measurement of hip, pelvis, spine | 386 | $4,334 | $11 |
| Nuclear medicine study, spect imaging with concurrent ct scan, 1 area or single acquisition, single day imaging | 65 | $4,103 | $63 |
| Nuclear medicine study whole body with ct scan | 36 | $4,025 | $106 |
| Radioactive drug therapy through a vein | 18 | $1,957 | $85 |
| Nuclear medicine study of bone and/or joint whole body | 40 | $1,386 | $35 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan | 14 | $1,180 | $84 |
| Dxa bone density measurement of hip, pelvis, spine | 84 | $927 | $11 |
| Nuclear medicine study of heart muscle with metabolic evaluation and concurrent ct scan | 11 | $837 | $76 |
| Nuclear medicine study of lymphatic system | 14 | $732 | $52 |
| Nuclear medicine study of stomach to assess emptying | 18 | $638 | $35 |
2020: 14 services
| Nuclear medicine study from skull base to mid-thigh with ct scan | 262 | $29,963 | $110 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 86 | $9,664 | $107 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 105 | $7,180 | $68 |
| Nuclear medicine study whole body with ct scan | 57 | $6,564 | $109 |
| Dxa bone density measurement of hip, pelvis, spine | 304 | $3,483 | $11 |
| Nuclear medicine study whole body with ct scan | 29 | $3,394 | $109 |
| Nuclear medicine study, spect imaging with concurrent ct scan, 1 area or single acquisition, single day imaging | 41 | $2,661 | $65 |
| Nuclear medicine study of bone and/or joint whole body | 61 | $2,241 | $37 |
| Radioactive drug therapy through a vein | 14 | $1,630 | $78 |
| Nuclear medicine study of lymphatic system | 26 | $1,310 | $50 |
| Nuclear medicine study of stomach to assess emptying | 28 | $1,007 | $36 |
| Nuclear medicine study, spect imaging, 1 area or single acquisition, single day imaging | 18 | $794 | $44 |
| Dxa bone density measurement of hip, pelvis, spine | 47 | $535 | $11 |
| Nuclear medicine study of lung circulation | 12 | $410 | $34 |
2019: 20 services
| Nuclear medicine study from skull base to mid-thigh with ct scan | 242 | $27,875 | $107 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 174 | $12,458 | $72 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 91 | $10,927 | $106 |
| Nuclear medicine study whole body with ct scan | 81 | $8,788 | $105 |
| Dxa bone density measurement of hip, pelvis, spine | 520 | $5,853 | $11 |
| Nuclear medicine study of bone and/or joint whole body | 91 | $3,497 | $36 |
| Nuclear medicine study whole body with ct scan | 26 | $2,861 | $110 |
| Nuclear medicine study of lymphatic system | 31 | $1,660 | $54 |
| Radioactive drug therapy through a vein | 14 | $1,481 | $78 |
| Nuclear medicine study of lung ventilation and circulation | 24 | $1,156 | $48 |
| Dxa bone density measurement of hip, pelvis, spine | 100 | $1,118 | $11 |
| Nuclear medicine study of stomach to assess emptying | 32 | $1,113 | $35 |
| Nuclear medicine study of parathyroid with spect and ct scan | 15 | $1,053 | $70 |
| Nuclear medicine study, spect imaging, 1 area or single acquisition, single day imaging | 22 | $1,047 | $46 |
| Nuclear medicine study of heart muscle at rest and with stress and spect | 16 | $864 | $54 |
| Nuclear medicine study of heart muscle with metabolic evaluation | 14 | $841 | $60 |
| Nuclear medicine study of bone taken at different times | 15 | $682 | $45 |
| Nuclear medicine study of radioactive material distribution at sites of inflammation in whole body | 14 | $478 | $32 |
| Nuclear medicine study of liver and bile duct system with use of drugs | 11 | $448 | $41 |
| Nuclear medicine study of liver and bile duct system | 11 | $366 | $33 |
2018: 26 services
| Nuclear medicine study from skull base to mid-thigh with ct scan | 254 | $28,357 | $105 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 224 | $15,146 | $68 |
| Nuclear medicine study whole body with ct scan | 101 | $11,369 | $103 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 98 | $10,910 | $107 |
| Dxa bone density measurement of hip, pelvis, spine | 654 | $7,564 | $12 |
| Nuclear medicine study of bone and/or joint whole body | 125 | $4,478 | $33 |
| Nuclear medicine study whole body with ct scan | 30 | $3,354 | $108 |
| Nuclear medicine study of stomach to assess emptying | 75 | $2,547 | $33 |
| Nuclear medicine study of lymphatic system | 45 | $2,372 | $52 |
| Nuclear medicine study of lung ventilation and circulation | 42 | $1,968 | $47 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 30 | $1,836 | $61 |
| Dxa bone density measurement of hip, pelvis, spine | 128 | $1,466 | $11 |
| Nuclear medicine study of parathyroid with spect and ct scan | 18 | $1,174 | $65 |
| Nuclear medicine study, spect imaging, 1 area or single acquisition, single day imaging | 22 | $1,022 | $46 |
| Nuclear medicine study of heart muscle at rest and with stress and spect | 17 | $1,001 | $56 |
| Nuclear medicine study of bone and/or joint | 22 | $997 | $45 |
| Nuclear medicine study of lymphatic system | 19 | $945 | $50 |
| Nuclear medicine study of bone taken at different times | 20 | $871 | $44 |
| Nuclear medicine study of heart muscle with metabolic evaluation | 12 | $737 | $61 |
| Calculation of radiation therapy dose | 22 | $681 | $30 |
| Nuclear medicine study of radioactive material distribution at sites of inflammation in whole body | 18 | $621 | $34 |
| Nuclear medicine study of liver and bile duct system with use of drugs | 15 | $603 | $40 |
| Nuclear medicine study of kidney, blood, flow, and function with drug administration | 11 | $568 | $52 |
| Nuclear medicine study, whole body | 13 | $449 | $35 |
| Nuclear medicine study of liver | 11 | $331 | $30 |
| Nuclear medicine study of thyroid and thyroid function | 13 | $265 | $20 |
2017: 18 services
| Nuclear medicine study from skull base to mid-thigh with ct scan | 430 | $50,349 | $106 |
| Nuclear medicine study whole body with ct scan | 99 | $11,437 | $108 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 98 | $11,324 | $108 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 77 | $5,549 | $70 |
| Nuclear medicine study of bone and/or joint whole body | 117 | $4,404 | $36 |
| Nuclear medicine study whole body with ct scan | 30 | $3,521 | $107 |
| Nuclear medicine study of lymphatic system | 56 | $3,024 | $53 |
| Nuclear medicine study of stomach to assess emptying | 54 | $1,867 | $35 |
| Nuclear medicine study of lung ventilation and circulation | 39 | $1,865 | $48 |
| Nuclear medicine study, spect imaging, 1 area or single acquisition, single day imaging | 26 | $1,217 | $45 |
| Nuclear medicine study of heart muscle with metabolic evaluation | 13 | $891 | $64 |
| Nuclear medicine study of parathyroid with spect and ct scan | 11 | $716 | $65 |
| Nuclear medicine study, whole body | 18 | $661 | $37 |
| Nuclear medicine study of bone and/or joint | 12 | $548 | $46 |
| Nuclear medicine study of liver | 18 | $547 | $30 |
| Calculation of radiation therapy dose | 15 | $443 | $30 |
| Nuclear medicine study of liver and bile duct system with use of drugs | 11 | $443 | $40 |
| Nuclear medicine study of radioactive material distribution at sites of inflammation in whole body | 12 | $434 | $36 |
2016: 8 services
| Nuclear medicine study from skull base to mid-thigh with ct scan | 197 | $21,673 | $107 |
| Nuclear medicine study whole body with ct scan | 36 | $3,902 | $108 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 38 | $2,700 | $71 |
| Nuclear medicine study of bone and/or joint whole body | 33 | $1,203 | $36 |
| Nuclear medicine study of lung ventilation and circulation | 18 | $819 | $45 |
| Nuclear medicine study of lymphatic system | 15 | $795 | $53 |
| Nuclear medicine study of stomach to assess emptying | 21 | $691 | $33 |
| Nuclear medicine study, spect imaging, 1 area or single acquisition, single day imaging | 11 | $514 | $47 |
2014: 7 services
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 127 | $8,132 | $64 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 34 | $3,550 | $101 |
| Nuclear medicine study of bone and/or joint whole body | 54 | $1,915 | $34 |
| Dxa bone density measurement of hip, pelvis, spine | 160 | $1,722 | $11 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 76 | $1,266 | $17 |
| Nuclear medicine study of lung ventilation and circulation | 22 | $889 | $40 |
| Nuclear medicine study of lung circulation | 23 | $708 | $29 |
2013: 8 services
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 100 | $6,249 | $62 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 37 | $3,736 | $98 |
| Dxa bone density measurement of hip, pelvis, spine | 191 | $1,963 | $10 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 79 | $1,398 | $18 |
| Nuclear medicine study of bone and/or joint whole body | 41 | $1,342 | $33 |
| Nuclear medicine study from skull base to mid-thigh | 13 | $1,038 | $80 |
| Nuclear medicine study of lung ventilation and circulation | 13 | $575 | $44 |
| Nuclear medicine study of lung circulation | 14 | $406 | $29 |
Medicaid work
$11,494 in 2024
Medicaid paid $11,494 for 85 billed services this clinician did in 2024, up to 22 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh | 63 | $11,437 |
| DXA BONE DENSITY STUDY 1/> SITES AXIAL SKEL | 22 | $57 |
| 2024 | 85 | 2 | 22 | $11,494 |
| 2023 | 207 | 2 | 30 | $25,649 |
| 2022 | 147 | 2 | 22 | $23,082 |
| 2021 | 155 | 2 | 25 | $14,220 |
| 2020 | 88 | 1 | 17 | $15,600 |
| 2019 | 103 | 2 | 24 | $10,459 |
| 2018 | 235 | 4 | 26 | $21,123 |
See the largest Medicaid services in earlier years
2023
| Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh | 137 | $25,242 |
| DXA BONE DENSITY STUDY 1/> SITES AXIAL SKEL | 70 | $407 |
2022
| Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh | 104 | $22,912 |
| DXA BONE DENSITY STUDY 1/> SITES AXIAL SKEL | 43 | $171 |
2021
| Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh | 88 | $13,880 |
| DXA BONE DENSITY STUDY 1/> SITES AXIAL SKEL | 67 | $340 |
2020
| Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh | 88 | $15,600 |
2019
| Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh | 56 | $10,218 |
| DXA BONE DENSITY STUDY 1/> SITES AXIAL SKEL | 47 | $242 |
2018
| Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh | 88 | $18,749 |
| Myocardial perfusion imaging, tomographic (SPECT) (including attenuation correction, qualitative or quantitative wall motion, ejection fraction by first pass or gated technique, additional quantification, when performed); multiple studies, at rest and/or stress (exercise or pharmacologic) and/or redistribution and/or rest reinjection | 16 | $859 |
| BONE IMAGING WHOLE BODY | 24 | $775 |
| DXA BONE DENSITY STUDY 1/> SITES AXIAL SKEL | 107 | $740 |
Money from drug and device companies
$85 in 2025
| 2025 | 1 | 1 | None | $85 |
| 2024 | 2 | 4 | None | $244 |
| 2023 | 1 | 3 | None | $310 |
| 2021 | 1 | 1 | $10,300 | $10,300 |
| 2020 | 1 | 3 | None | $171 |
| 2019 | 1 | 17 | None | $14,270 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Telix Pharmaceuticals | Illuccix | $85 | 1 payment
|
See the published payment
| Telix Pharmaceuticals | Meals · 2025-02-01 | Illuccix | $85 |
See earlier years (2024, 2023, 2021, 2020, 2019)
2024: $244
| Ge Healthcare | None | $204 | 3 payments
|
| Siemens Medical Solutions USA | None | $39 | 1 payment
|
2023: $310
| GE HealthCare | None | $310 | 3 payments
|
2021: $10,300
| Jubilant DraxImage | Ruby-Fill | $10,300 | 1 payment
|
2020: $171
| Ge Healthcare | None | $171 | 3 payments
|
2019: $14,270
| Ge Healthcare | None | $14,270 | 17 payments
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1215238209
- Licence
- CA A117782, IL 036133414California A117782: Current · expires 2027-08-31Illinois 036133414: Not Renewed
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 2085N0904X (2085N0904X); Federal specialty code 207U00000X (207U00000X); Federal specialty code 207UN0902X (207UN0902X); Diagnostic radiology (2085R0202X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2010-11-08
- NPI last updated
- 2024-04-09
- NPI record certified
- 2024-04-09
This is when the NPI record was last certified, not a medical board exam.